Clinical Trial

Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 27, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This clinical trial evaluates lymph node mapping in newly diagnosed endometrial cancer patients undergoing surgery. The standard technique uses a 2-point methylene blue cervical injection. The study aims to determine if increasing injection points improves mapping success.
Trial Details
NCT Number NCT07040657
Lead Sponsor Dokuz Eylul University
Conditions Endometrial Neoplasms, Endometrial Cancer Stage I, Sentinel Lymph Node, Metastasis
Enrollment 100 participants
Start Date 2025-05-01
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-27